Insider · CIK 0001694560
New Enterprise Associates 16, L.P.
Files at MRKR (Marker Therapeutics, Inc.), NEUE (NeueHealth, Inc.). First filing Dec 23, 2024, latest Oct 6, 2025.
New Enterprise Associates 16, L.P. files SEC Form 4 as 10% owner and director at MRKR (Marker Therapeutics, Inc.), and also at NEUE (NeueHealth, Inc.). Since Dec 23, 2024, New Enterprise Associates 16, L.P. has reported 1 open-market buy worth $1.8M and 1 open-market sell worth $1,890, the latest filed on Oct 6, 2025.
A track record needs three past buys with six months of prices behind them; New Enterprise Associates 16, L.P. has 0, so none is measured yet.
The newest scored trade: sold $1,890 of NEUE on Oct 2, 2025, filed Oct 6, 2025, scored 15 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MRKR: Marker Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | NeueHealth, Inc. | $1,890 280 shares | -0% | - | |
| 50Moderate | Marker Therapeutics, Inc. | $1.8M 554,250 shares | +52% | - |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stock | +189,195 | $0.01 | $1,892 | 788,259 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stock | -280 | $6.75 | $1,890 | 787,979 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stock | +372,255 | $0.01 | $3,723 | 1,160,234 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stock | -551 | $6.75 | $3,719 | 1,159,683 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stock | -1,159,683 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivative | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivative | +372,255 | - | - | 372,255 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivative | -372,255 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Dec 23, 2024 | MRKR Marker Therapeutics, Inc. | POpen-market purchase Common Stock | +554,250 | $3.20 | $1.8M | 1,625,678 | Dec 23, 2024 |
Questions about New Enterprise Associates 16, L.P.
Answered from the filings on this page, as of the latest one.
Is New Enterprise Associates 16, L.P. buying or selling?
Not in the last 12 months. New Enterprise Associates 16, L.P.'s latest open-market trade on SEC Form 4 was sold $1,890 of NEUE on Oct 2, 2025.
How did New Enterprise Associates 16, L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and New Enterprise Associates 16, L.P. has 0.
Where does New Enterprise Associates 16, L.P. file Form 4?
New Enterprise Associates 16, L.P. has filed Form 4 at MRKR (Marker Therapeutics, Inc.); NEUE (NeueHealth, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.